Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

More News From tech.aseancoverage.com

Toyota, SoftBank fund, Denso invest $1 billion in Uber

Apr 25, 2019

TOKYO — Japan's top automaker Toyota, auto parts maker Denso and internet company SoftBank's investment fund are investing $1 billion in car-sharing Uber's technology unit. The Japanese companies said Friday that Toyota Motor Corp. and Denso Corp. will together invest $667 million and SoftBank Corp.'s Vision Fund will contribute $333 million in Uber Technologies Inc.'s new entity, Advanced Technologies Group, or Uber ATG, which will try to develop and commercialize automated ridesharing services. The move comes as Toyota steps up such efforts, including investing $500 million in Uber, based in San Francisco, and setting up a $20 million joint venture...

Asian stocks sink after Wall Street declines

Apr 25, 2019

BEIJING — Asian stocks fell Thursday after Wall Street declined despite encouraging Chinese economic data. Benchmarks in Shanghai, Tokyo, Seoul and Hong Kong all retreated. Sydney was little-changed. U.S. stocks fell despite data showing growth in China's gross domestic product held steady in the latest quarter in the face of a tariff war with Washington and consumer spending accelerated. "The surprisingly robust China GDP data failed to ignite a rally on Wall Street as U.S. investors turn focus to domestic concerns," said Stephen Innes of SPI Asset Management in a report. He said investors are "increasingly cautious" about possibly misreading...

Death of rare turtle leaves 3 remaining in the world

Apr 25, 2019

BEIJING — The only known female member of one of the world's rarest turtle species has died at a zoo in southern China, officials said Sunday. The animal was one of four Yangtze giant softshell turtles known to be remaining in the world. The Suzhou zoo, where the female turtle lived, also houses a male Yangtze giant softshell turtle. The other two live in Vietnam, but their genders are unknown. The turtle died Saturday afternoon, the Suzhou city government said in a statement, citing the zoo. It said experts have already used technology to collect the turtle's ovarian tissue for...

China, Japan tout 'recovered' ties amid global uncertainty

Apr 25, 2019

BEIJING — China and Japan have the opportunity to "take charge of the economic field" during a time of worldwide uncertainty, Japan's foreign minister said Sunday, as trade pressures from the United States have prompted both countries to seek alternative markets. Foreign Minister Taro Kono met with his Chinese counterpart, Wang Yi, in Beijing to discuss youth exchanges and economic relations between the two countries, whose ties "completely recovered" last year, according to Kono. The relationship was turbulent in previous years due to an unresolved dispute over islands in the East China Sea. High-level exchanges were frozen in 2012 after...

China exports rise in March, rebounding from slump

Apr 25, 2019

BEIJING — China's exports rebounded from a slump in March and sales to the United States rose despite President Donald Trump's tariff hikes. Exports rose 14.2% over a year ago to $198.7 billion, recovering from February's 20.8% contraction, customs data showed Friday. Imports fell 7.6% to $166 billion, worsening the previous month's 5.2% decline. Exports to the United States rose 3.7% to $31.8 billion, recovering from February's 28.6% decline despite Trump's tariffs of up to 25% on $250 billion of Chines goods. Imports of American goods plunged 25.8% to $11.3 billion, hit by Chinese retaliatory duties and orders to buyers...

AseanCoverage is a next-gen news site focusing exclusively on online news from South East Asia.

Contact us: sales[at]aseancoverage.com